Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intra-Cellular Ther (ITCI)

Intra-Cellular Ther (ITCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 478,008
  • Shares Outstanding, K 55,261
  • Annual Sales, $ 0 K
  • Annual Income, $ -155,130 K
  • 60-Month Beta 1.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.91
  • Number of Estimates 3
  • High Estimate -0.78
  • Low Estimate -1.03
  • Prior Year -0.75
  • Growth Rate Est. (year over year) -21.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.11 +10.11%
on 10/21/19
10.20 -12.45%
on 11/06/19
+0.65 (+7.85%)
since 10/18/19
3-Month
6.75 +32.30%
on 10/01/19
11.00 -18.82%
on 09/10/19
-0.15 (-1.65%)
since 08/19/19
52-Week
6.75 +32.30%
on 10/01/19
16.76 -46.72%
on 12/11/18
-6.33 (-41.48%)
since 11/19/18

Most Recent Stories

More News
Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock

Investors need to pay close attention to Intra-Cellular Therapies (ITCI) stock based on the movements in the options market lately.

ITCI : 8.99 (+3.93%)
Top Ranked Momentum Stocks to Buy for November 11th

Top Ranked Momentum Stocks to Buy for November 11th

LUNA : 6.50 (+0.31%)
ITCI : 8.99 (+3.93%)
FLGT : 11.48 (+6.20%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , SUPN , MDCO , PRGO , CTLT )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 8.99 (+3.93%)
MDCO : 69.69 (+18.82%)
SUPN : 21.98 (-0.27%)
Intra-Cellular: 3Q Earnings Snapshot

NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Tuesday reported a loss of $34.9 million in its third quarter.

ITCI : 8.99 (+3.93%)
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today provided a corporate update and announced...

ITCI : 8.99 (+3.93%)
Intra-Cellular Therapies Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Intra-Cellular Therapies.

ITCI : 8.99 (+3.93%)
Intra-Cellular Therapies to Host Third Quarter 2019 Financial Results Conference Call and Webcast

Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference...

ITCI : 8.99 (+3.93%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Intra-Cellular T (ITCI , HZNP , ZTS , LCI , LLY )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

HZNP : 30.60 (-0.42%)
ITCI : 8.99 (+3.93%)
ZTS : 119.59 (+0.66%)
Relatively Good Performance Detected in Shares of Nektar Therapeut in the Pharmaceuticals Industry (NKTR , ITCI , RVNC , PCRX , LCI )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ITCI : 8.99 (+3.93%)
NKTR : 18.39 (+2.11%)
RVNC : 16.02 (+0.50%)
Shares of Intersect Ent In Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (XENT , ITCI , MDCO , AGN , LLY )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

XENT : 21.46 (+1.75%)
ITCI : 8.99 (+3.93%)
MDCO : 69.69 (+18.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ITCI with:

Business Summary

Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular...

See More

Key Turning Points

2nd Resistance Point 9.24
1st Resistance Point 8.95
Last Price 8.99
1st Support Level 8.46
2nd Support Level 8.27

See More

52-Week High 16.76
Fibonacci 61.8% 12.94
Fibonacci 50% 11.76
Fibonacci 38.2% 10.57
Last Price 8.99
52-Week Low 6.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar